BARLOW CARROLEE received a stock award from SUPERNUS PHARMACEUTICALS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 2/23/2022ACC: 0001104659-22-026108
Director
Since Jun 2018
0.00
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
4.22K acquired · 4.22K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
+4.22K
Price / share
—
Trade value
—
% of position
81.0%
2/19/2022
5.21K→9.43K
Total
Net shares
+4.22K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/19/2022 | A · Award | +4.22K | — | — | 81.0% | 5.21K | 9.43K |
| Total | +4.22K | $0.00 | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Stock
4.22K shares
Shares
−4.22K
Strike price
Held after
0.00
Exercisable
—
2/19/2022
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock4.22K shares | 2/19/2022 | D · Disposition | −4.22K | — | 0.00 |